menu search

Us earthquake - seattle buildings swaying

Magnitude 4.53 km SW of marrowstone, Washington statedepth 55kmmore to comeMap via USGS showing the Pug...

October 9, 2023, 2:29 am

Be the match raises $1.1 million at annual gala

Funds raised support saving more lives through blood stem cell transplants MINNEAPOLIS, Oct. 05, 2023 (GLOBE NEWSWIRE) — On Saturday, September 30, ...

October 5, 2023, 1:18 pm

Angle hails the latest breast cancer study

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the liquid biopsy and cancer diagnostics specialist, has hailed a study that could change the way doctors monitor a...

October 3, 2023, 2:46 am

Us fda approves gsk's anemia treatment

British drugmaker GSK Plc said on Friday the U.S. Food and Drug Administration had approved its experimental drug to treat anemic patients with a type...

September 15, 2023, 4:25 pm

Biolinerx rallies on fda approval of aphexda with filgrastim

Bioline RX Ltd (NASDAQ:BLRX) shares jumped at the market open on Monday after the US Food and Drug Administration approved the use of Aphexda (motixa...

September 11, 2023, 9:58 am

Biocardia shares slide on disappointing interim data from heart therapy trial

BioCardia shares fell more than 20% in pre-market trade on Tuesday after the biopharmaceutical firm revealed that its Phase 3 trial of CardiAMP cell t...

September 5, 2023, 9:31 am

Pfizer gets fda accelerated approval for multiple myeloma treatment

A Pfizer Inc. PFE, +0.52% treatment for relapsed or refractory multiple myeloma has received accelerated approval from the U.S. Food and Drug Administ...

August 14, 2023, 2:40 pm

Why shares of mesoblast are down monday

Several analysts have recently downgraded their positions on the pharmaceutical stock. Mesoblast focuses on therapies derived from the cells of the bo...

August 7, 2023, 12:01 pm

Fda rejects mesoblast's cell therapy for bone marrow transplant complications

The U.S. Food and Drug Administration had rejected Mesoblast's , cell therapy for children under 12 years of age for treating a type of complication t...

August 3, 2023, 10:01 pm

Gsk says fda extends review period for experimental drug momelotinib

British drugmaker GSK Plc on Friday said the U.S. Food and Drug Administration has extended the review period for its experimental drug momelotinib, w...

June 16, 2023, 2:29 am

Precipio’s omnia™ methodology enables diagnosis of mds with peripheral blood instead of bone marrow biopsy

Use of HemeScreen® technology enables diagnosis without the need for painful, invasive sampling NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) — ...

June 14, 2023, 1:49 pm

Why shares of cti biopharma are soaring wednesday

CTI BioPharma has one FDA-approved therapy, Vonjo, to treat a rare form of bone marrow cancer. The comp...

May 10, 2023, 10:51 am

In8bio to present new positive clinical data from phase 1 trial of inb-100 at ebmt 2023 annual meeting

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing innova...

April 11, 2023, 8:00 am

Qiagen (qgen) to develop cdx test for tibsovo with new pact

QIAGEN (QGEN) will develop a real-time in vitro PCR test that can be utilized to spot IDH1 gene mutations in AML patients in whole blood and bone ...

March 10, 2023, 11:29 am

Stem cell therapy market size worth usd 92.08 million by 2030 at 16.20% cagr – report by market research future (mrfr)

Stem Cell Therapy Market Growth, Trends and Size Analysis by Cell Source (Adipose Tissue, Bone marrow, ...

March 6, 2023, 2:45 pm

Jasper therapeutics shares jump after announcing new clinical data

Shares of Jasper Therapeutics Inc. JSPR, +318.31% soared 283% in trading on Tuesday after the company said in a news release that its experimental the...

January 3, 2023, 10:40 am

Nexcella, inc announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car t-cell meeting

Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...

December 28, 2022, 1:05 pm

Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car

Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...

December 28, 2022, 1:00 pm

Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car

Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...

December 28, 2022, 1:00 pm

Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car

Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...

December 28, 2022, 1:00 pm


Search within

Pages Search Results: